116 related articles for article (PubMed ID: 18177798)
21. Update on the diagnosis and therapy of distant metastases of differentiated thyroid carcinoma.
Zanotti-Fregonara P; Hindié E; Faugeron I; Moretti JL; Ravasi L; Rubello D; Toubert ME
Minerva Endocrinol; 2008 Dec; 33(4):313-27. PubMed ID: 18923368
[TBL] [Abstract][Full Text] [Related]
22. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
23. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
[TBL] [Abstract][Full Text] [Related]
24. Initial surgical management of thyroid cancer.
Witt RL
Surg Oncol Clin N Am; 2008 Jan; 17(1):71-91, viii. PubMed ID: 18177801
[TBL] [Abstract][Full Text] [Related]
25. Multi-targeted approach in the treatment of thyroid cancer.
Zarebczan B; Chen H
Minerva Chir; 2010 Feb; 65(1):59-69. PubMed ID: 20212418
[TBL] [Abstract][Full Text] [Related]
26. Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data.
Vang R; Shih IeM; Salani R; Sugar E; Ayhan A; Kurman RJ
Am J Surg Pathol; 2008 Nov; 32(11):1667-74. PubMed ID: 18769340
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide studies in thyroid neoplasia.
Giordano TJ
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):311-31, vii-viii. PubMed ID: 18502329
[TBL] [Abstract][Full Text] [Related]
28. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide gene expression profiles of thyroid carcinoma: Identification of molecular targets for treatment of thyroid carcinoma.
Nikolova DN; Zembutsu H; Sechanov T; Vidinov K; Kee LS; Ivanova R; Becheva E; Kocova M; Toncheva D; Nakamura Y
Oncol Rep; 2008 Jul; 20(1):105-21. PubMed ID: 18575725
[TBL] [Abstract][Full Text] [Related]
30. Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.
Llobet D; Pallares J; Yeramian A; Santacana M; Eritja N; Velasco A; Dolcet X; Matias-Guiu X
J Clin Pathol; 2009 Sep; 62(9):777-85. PubMed ID: 18977806
[TBL] [Abstract][Full Text] [Related]
31. Contemporary management of papillary carcinoma of the thyroid gland.
Rosenbaum MA; McHenry CR
Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
[TBL] [Abstract][Full Text] [Related]
32. Airway management in anaplastic thyroid carcinoma.
Shaha AR
Laryngoscope; 2008 Jul; 118(7):1195-8. PubMed ID: 18438260
[TBL] [Abstract][Full Text] [Related]
33. Medullary thyroid cancer: early detection and novel treatments.
Roman S; Mehta P; Sosa JA
Curr Opin Oncol; 2009 Jan; 21(1):5-10. PubMed ID: 19125012
[TBL] [Abstract][Full Text] [Related]
34. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL
Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701
[TBL] [Abstract][Full Text] [Related]
35. [Schilddrüse und polyendokrinopathien].
Luger A
Wien Med Wochenschr; 2005 Oct; 155(19-20):454-7. PubMed ID: 16425001
[TBL] [Abstract][Full Text] [Related]
36. CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis.
Lui WO; Zeng L; Rehrmann V; Deshpande S; Tretiakova M; Kaplan EL; Leibiger I; Leibiger B; Enberg U; Höög A; Larsson C; Kroll TG
Cancer Res; 2008 Sep; 68(17):7156-64. PubMed ID: 18757431
[TBL] [Abstract][Full Text] [Related]
37. Overview on the use of recombinant human thyrotropin in thyroid cancer of follicular cell origin.
Zanotti-Fregonara P; Toubert ME; Taieb D; Ravasi L; Rubello D; Hindie E
Minerva Endocrinol; 2008 Jun; 33(2):53-65. PubMed ID: 18332849
[TBL] [Abstract][Full Text] [Related]
38. [Research advances in molecular pathogenesis of thyroid cancer].
Aleha M; Meng QB; Yu JC; Kang WM; Cao ZJ; Tian SB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):382-5. PubMed ID: 23987483
[TBL] [Abstract][Full Text] [Related]
39. Modern approaches to age-old questions about thyroid tumors.
Diehl S; Umbricht CB; Dackiw AP; Zeiger MA
Thyroid; 2005 Jun; 15(6):575-82. PubMed ID: 16029124
[TBL] [Abstract][Full Text] [Related]
40. Protocol of the diagnostic, therapy and follow-up of differentiated thyroid cancer.
Stefanović L; Gudurić B; Sljapić N; Babić J; Miljković L; Malesević M; Bogdanović J
Med Pregl; 1993; 46 Suppl 1():90-1. PubMed ID: 8569622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
